TOPICAL FORMULATION

摘要

The invention relates to composition and related therapeutic methods including at least one antihyperthyroid drug formulated for transdermal administration. Because the formulation is formulated for transdermal administration, the formulation is easier to administer than existing formulations which are administered orally to animals. Issues surrounding transdermal adminis-tration versus oral administration have also been resolved allowing the agent to remain stable during storage and retain a high level of efficacy.